Has HUMANWELL PURACAP had other FDA enforcement actions?

This is the only FDA action Argus HQ has on file for HUMANWELL PURACAP as of 2026-07-15. Argus ingests new FDA enforcement records daily.

What kind of FDA record is this?

This is an Argus HQ record of a FDA Drug Approval, tagged info severity by Argus HQ. FDA published the underlying record on 2026-07-09; Argus observed and indexed it on 2026-07-15.

Where can I verify this record directly with FDA?

The verbatim FDA source record is the source of truth — Argus HQ links directly to it below. Always confirm against fda.gov before acting.

.hq

fda_approval · anda · info

HUMANWELL PURACAP — ANDA approval: NINTEDANIB ESYLATE (unspecified)

Name: FDA Drug Approval Record — HUMANWELL PURACAP
Creator: Argus HQ
Published: 2026-07-09
License: https://argushq.ai/methodology

Event date: 2026-07-09 00:00:00Z
Observed: 2026-07-15 04:30:20Z
Source ID: ANDA218472-1
Payload hash: 2df7a6d1121e567ac54a6122…

Summary

HUMANWELL PURACAP received ANDA approval for NINTEDANIB ESYLATE (unspecified) on 2026-07-09. Dosage form: CAPSULE. Application #: ANDA218472.

Entities

HUMANWELL PURACAP

View source record ↗

Frequently asked questions

Has HUMANWELL PURACAP had other FDA enforcement actions?: This is the only FDA action Argus HQ has on file for HUMANWELL PURACAP as of 2026-07-15. Argus ingests new FDA enforcement records daily.
What kind of FDA record is this?: This is an Argus HQ record of a FDA Drug Approval, tagged info severity by Argus HQ. FDA published the underlying record on 2026-07-09; Argus observed and indexed it on 2026-07-15.
Where can I verify this record directly with FDA?: The verbatim FDA source record is the source of truth — Argus HQ links directly to it below. Always confirm against fda.gov before acting.

Compiled by Argus HQ Research from FDA primary sources · Reviewed by Andy Gaber, Founder

Cite this record

Reusing this data in reporting or research? Here’s a ready-made citation.

APA

Argus HQ Research (2026). HUMANWELL PURACAP — ANDA approval: NINTEDANIB ESYLATE (unspecified). Digital Empire LLC. Retrieved from https://argushq.ai/events/fda-approval-humanwell-puracap-anda218472-1

MLA

"HUMANWELL PURACAP — ANDA approval: NINTEDANIB ESYLATE (unspecified)." Argus HQ Research, Digital Empire LLC, 2026, argushq.ai/events/fda-approval-humanwell-puracap-anda218472-1.

Chicago

Argus HQ Research. "HUMANWELL PURACAP — ANDA approval: NINTEDANIB ESYLATE (unspecified)." Digital Empire LLC. Accessed July 15, 2026. https://argushq.ai/events/fda-approval-humanwell-puracap-anda218472-1.

BibTeX

@misc{argushq_argushq_ai_events_fda_approval_humanwell_puracap_anda218472_1_2026,
  title = {HUMANWELL PURACAP — ANDA approval: NINTEDANIB ESYLATE (unspecified)},
  author = {{Argus HQ Research}},
  year = {2026},
  publisher = {Digital Empire LLC},
  url = {https://argushq.ai/events/fda-approval-humanwell-puracap-anda218472-1},
  note = {Accessed: July 15, 2026}
}

Informational only. Not legal, financial, or medical advice.